Brief: Cue Biopharma Announces First Patient Dosed In Part B Patient Expansion Of Cue-101 Phase 1 Monotherapy Trial In Hpv+ Second Line And Beyond Hnscc
10/06/2021 13:14
June 10 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN PART B
PATIENT
EXPANSION OF CUE-101 PHASE 1 MONOTHERAPY TRIAL IN HPV+ SECOND
LINE AND BEYOND HNSCC
Source text for Eikon: ID:nGNX34fqKB
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))